Skip to main content

Advertisement

Table 1 Clinicopathological parameters and the expression of miR-204-5p in NSCLC. Annotation: n number, SD standard deviation, NSCLC non-small cell lung cancer. a, paired sample’s t test performed to compare miR-204-5p expression between NSCLC and the controls; Independent sample’s t test processed to assess relationships between miR-30d-5p expression and the clinicopathological parameters of NSCLC. TNM, tumor, node, metastasis; b, One-way ANOVA preformed to evaluate distributive feature of miR-204-5p in three or more groups of clinicopathological parameters

From: Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses

Clinicopathological parametersnRelevant expression of miR-204-5p (2−ΔCq)
Mean ± SDt/F-valuep-value
TissueNSCLC1253.6760 ± 1.87670-3.507a0.001
Non-cancer1254.6487 ± 2.46888
GenderMale754.0067 ± 1.918432.4610.015
Female503.1800 ± 1.71357
Age (years)< 60573.9526 ± 1.818471.5170.132
> = 60683.4441 ± 1.90650
SmokeNo384.3368 ± 1.70205−0.1080.914
Yes304.3833 ± 1.83041
Histological typeAdenocarcinoma1013.4663 ± 1.82397−2.9020.004
Squamous carcinoma234.6870 ± 1.80638
Tumor size<=3 cm603.2417 ± 1.78547−2.5400.012
> 3 cm654.0769 ± 1.88280
Vascular invasionNo904.2233 ± 1.688765.898< 0.001
Yes352.2686 ± 1.59609
TNMI-II544.0870 ± 1.963832.1670.032
III-IV713.3634 ± 1.75770
Lymph node metastasisNo564.2089 ± 1.958972.9480.004
Yes693.2435 ± 1.70142
Pathological gradingI174.2176 ± 1.941402.797b0.065
II783.8090 ± 1.85404
III303.6760 ± 1.87670